Evaluation of molecular response to imatinib mesylate treatment in Iranian patients with chronic myeloid leukemia Evaluation of molecular response to generic Imatinib treatment in Iranian patients with chronic myeloid leukemia

ConclusionsThe data of this prospective study are highly comparable to clinical trials and prospective international studies
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research